The presence of circulating anticyclic citrullinated protein antibodies (ACPAs) is a very specific finding in patients with rheumatoid arthritis (RA). "Source Future Rheumatology http://www.futuremedicine.com/doi/abs/10.2217/17460816.2.6.577?cookieSet=1&journalCode=frm"
No
When your heart doesn't function you can't feel the effects of rheumatoid arthritis.
Arthritis comes in over a hundred different forms. However when referring to rheumatoid arthritis a blood test is done the checks for rheumatoid factor (RF). In about 70to 80% of cases rheumatoid arthritis will be accompanied by a positive RF. However in the rest of the cases where all indicators point to Rheumatoid arthritis and where no RF is found it is referred to a seronegative rheumatoid arthritis.
Between 2 to 3% of them have Rheumatoid arthritis
No
Sometimes causes lung disease in People who have had rheumatoid arthritis for an extended period of time.those between the ages of 50 and 60 seem to be the most likely to develop rheumatoid arthritis-related lung disease. Occasionally, however, lung problems surface before the joint inflammation and pain of rheumatoid arthritis.
This is not known as the cause of it is unknown as well as the relationship between RF and the activity of the disease.
For one thing Seronegative spondyloarthropathy shows a negative rheumatoid factor.
If you are commenting on whether or atmospheric condition there is no relationship between the weather altitude or humidity and the symptoms of RA At least none that have been scientifically proven.
Ankylosing spondylitis is a form of arthritis that primarily affects the joints between the vertebrae.
The exact cause for Rheumatoid arthritisis not known however there seems to be no known connection between Spina Bifida and Rheumatoid arthritis. Spina Bifida seems to be caused by a deficiency of folic acid during pregnancy, while arthritis is an auto-immune disease. As people age, though, they are prone to developing arthritis in overused joints.
For information on this subject go to the related link (MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis) Below